Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Breast Lesion Localization Methods Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising prevalence of breast cancer among women
3.2.1.2. Increasing awareness through cancer screening programs
3.2.1.3. Technological advancements
3.2.1.4. Availability of various techniques
3.2.1.5. Demand for minimally invasive and accurate procedures
3.2.2. Market Restraints Analysis
3.2.2.1. Risk associated with breast localization methods
3.2.2.2. Presence of complicated regulatory framework
3.3. Breast Lesion Localization Methods Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Breast Lesion Localization Methods Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Breast Lesion Localization Methods Market: Type Movement Analysis, USD Million, Volume Unit, 2023 & 2030
4.3. Global Breast Lesion Localization Methods Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million, Volume Unit,)
4.4. Wire Guided Localization
4.4.1. Wire guided localization market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)
4.5. Radioisotope Localization
4.5.1. Radioisotope localization market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.2. Radio guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.2.1. Radio Guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.3. Radio guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.3.1. Radio Guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.4. Radioactive-seed localization (RSL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.4.1. Radioactive-seed localization (RSL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.5. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.5.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.6. Magnetic Tracer
4.6.1. Magnetic tracer market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.7. Others
4.7.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)
Chapter 5. Breast Lesion Localization Methods Market: Regional Estimates & Trend Analysis by Type
5.1. Regional Dashboard
5.2. Market Size and Trend Analysis, 2018 to 2030
5.3. North America
5.3.1. North America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.2. U.S.
5.3.2.1. Key country dynamics
5.3.2.2. Competitive scenario
5.3.2.3. Regulatory framework
5.3.2.4. Reimbursement scenario
5.3.2.5. U.S. breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.3. Canada
5.3.3.1. Key country dynamics
5.3.3.2. Competitive scenario
5.3.3.3. Regulatory framework
5.3.3.4. Reimbursement scenario
5.3.3.5. Canada breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.4. Mexico
5.3.4.1. Key country dynamics
5.3.4.2. Competitive scenario
5.3.4.3. Regulatory framework
5.3.4.4. Reimbursement scenario
5.3.4.5. Mexico breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4. Europe
5.4.1. Europe breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. UK
5.4.2.1. Key country dynamics
5.4.2.2. Competitive scenario
5.4.2.3. Regulatory framework
5.4.2.4. Reimbursement scenario
5.4.2.5. UK breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.3. Germany
5.4.3.1. Key country dynamics
5.4.3.2. Competitive scenario
5.4.3.3. Regulatory framework
5.4.3.4. Reimbursement scenario
5.4.3.5. Germany breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.4. France
5.4.4.1. Key country dynamics
5.4.4.2. Competitive scenario
5.4.4.3. Regulatory framework
5.4.4.4. Reimbursement scenario
5.4.4.5. France breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.5. Italy
5.4.5.1. Key country dynamics
5.4.5.2. Competitive scenario
5.4.5.3. Regulatory framework
5.4.5.4. Reimbursement scenario
5.4.5.5. Italy breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.6. Spain
5.4.6.1. Key country dynamics
5.4.6.2. Competitive scenario
5.4.6.3. Regulatory framework
5.4.6.4. Reimbursement scenario
5.4.6.5. Spain breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Competitive scenario
5.4.7.3. Regulatory framework
5.4.7.4. Reimbursement scenario
5.4.7.5. Sweden breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.8. Denmark
5.4.8.1. Key country dynamics
5.4.8.2. Competitive scenario
5.4.8.3. Regulatory framework
5.4.8.4. Reimbursement scenario
5.4.8.5. Denmark breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.9. Norway
5.4.9.1. Key country dynamics
5.4.9.2. Competitive scenario
5.4.9.3. Regulatory framework
5.4.9.4. Reimbursement scenario
5.4.9.5. Norway breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Competitive scenario
5.5.2.3. Regulatory framework
5.5.2.4. Reimbursement scenario
5.5.2.5. China breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Japan
5.5.3.1. Key country dynamics
5.5.3.2. Competitive scenario
5.5.3.3. Regulatory framework
5.5.3.4. Reimbursement scenario
5.5.3.5. Japan breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.4. India
5.5.4.1. Key country dynamics
5.5.4.2. Competitive scenario
5.5.4.3. Regulatory framework
5.5.4.4. Reimbursement scenario
5.5.4.5. India breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Competitive scenario
5.5.5.3. Regulatory framework
5.5.5.4. Reimbursement scenario
5.5.5.5. South Korea breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.6. Australia
5.5.6.1. Key country dynamics
5.5.6.2. Competitive scenario
5.5.6.3. Regulatory framework
5.5.6.4. Reimbursement scenario
5.5.6.5. Australia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.7. Thailand
5.5.7.1. Key country dynamics
5.5.7.2. Competitive scenario
5.5.7.3. Regulatory framework
5.5.7.4. Reimbursement scenario
5.5.7.5. Thailand breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Latin America
5.6.1. Latin America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.2. Brazil
5.6.2.1. Key country dynamics
5.6.2.2. Competitive scenario
5.6.2.3. Regulatory framework
5.6.2.4. Reimbursement scenario
5.6.2.5. Brazil breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3. Argentina
5.6.3.1. Key country dynamics
5.6.3.2. Competitive scenario
5.6.3.3. Regulatory framework
5.6.3.4. Reimbursement scenario
5.6.3.5. Argentina breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Middle East and Africa
5.7.1. Middle East and Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.2. South Africa
5.7.2.1. Key country dynamics
5.7.2.2. Competitive scenario
5.7.2.3. Regulatory framework
5.7.2.4. Reimbursement scenario
5.7.2.5. South Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.3. Saudi Arabia
5.7.3.1. Key country dynamics
5.7.3.2. Competitive scenario
5.7.3.3. Regulatory framework
5.7.3.4. Reimbursement scenario
5.7.3.5. Saudi Arabia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.4. UAE
5.7.4.1. Key country dynamics
5.7.4.2. Competitive scenario
5.7.4.3. Regulatory framework
5.7.4.4. Reimbursement scenario
5.7.4.5. UAE breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.5. Kuwait
5.7.5.1. Key country dynamics
5.7.5.2. Competitive scenario
5.7.5.3. Regulatory framework
5.7.5.4. Reimbursement scenario
5.7.5.5. Kuwait breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Market Share Analysis, 2023
6.4. Company Heat Map Analysis
6.5. Strategy Mapping
6.5.1. Expansion
6.5.2. Mergers & Acquisition
6.5.3. Partnerships & Collaborations
6.5.4. New Product Launches
6.5.5. Research And Development
6.5.6. Company Profiles
6.5.7. BD
6.5.7.1. Company overview
6.5.7.2. Financial performance
6.5.7.3. Product Benchmarking
6.5.7.4. Strategic initiatives
6.5.8. SOMATEX Medical Technologies GmbH
6.5.8.1. Company overview
6.5.8.2. Financial performance
6.5.8.3. Product Benchmarking
6.5.8.4. Strategic initiatives
6.5.9. Argon Medical Devices
6.5.9.1. Company overview
6.5.9.2. Financial performance
6.5.9.3. Product Benchmarking
6.5.9.4. Strategic initiatives
6.5.10. Merit Medical Systems
6.5.10.1. Company overview
6.5.10.2. Financial performance
6.5.10.3. Product Benchmarking
6.5.10.4. Strategic initiatives
6.5.11. Cook Medical
6.5.11.1. Company overview
6.5.11.2. Financial performance
6.5.11.3. Product Benchmarking
6.5.11.4. Strategic initiatives
6.5.12. STERYLAB S.r.l.
6.5.12.1. Company overview
6.5.12.2. Financial performance
6.5.12.3. Product Benchmarking
6.5.12.4. Strategic initiatives
6.5.13. Theragenics Corporation
6.5.13.1. Company overview
6.5.13.2. Financial performance
6.5.13.3. Product Benchmarking
6.5.13.4. Strategic initiatives
6.5.14. MDL SRL
6.5.14.1. Company overview
6.5.14.2. Financial performance
6.5.14.3. Product Benchmarking
6.5.14.4. Strategic initiatives
6.5.15. MOLLI Surgical
6.5.15.1. Company overview
6.5.15.2. Financial performance
6.5.15.3. Product Benchmarking
6.5.15.4. Strategic initiatives
6.5.16. Mermaid Medical
6.5.16.1. Company overview
6.5.16.2. Financial performance
6.5.16.3. Product Benchmarking
6.5.16.4. Strategic initiatives
6.5.17. IsoAid
6.5.17.1. Company overview
6.5.17.2. Financial performance
6.5.17.3. Product Benchmarking
6.5.17.4. Strategic initiatives
6.5.18. Intramedical Imaging, LLC
6.5.18.1. Company overview
6.5.18.2. Financial performance
6.5.18.3. Product Benchmarking
6.5.18.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
Table 3 North America breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 4 U.S. breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 5 Canada breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 6 Mexico breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 7 Europe breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
Table 8 Europe breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 9 Germany breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 10 UK breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 11 lesion localization methods market, by end-use, 2018 - 2030 (USD Million)
Table 12 France breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 13 Italy breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 14 Spain breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 15 Denmark breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 16 Sweden breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 17 Norway breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 18 Asia Pacific breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
Table 19 Asia Pacific breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 20 China breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 21 Japan breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 22 India breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 23 South Korea breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 24 Australia breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 25 Thailand breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 26 Latin America breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
Table 27 Latin America breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 28 Brazil breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 29 Argentina breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 30 MEA breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
Table 31 MEA breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 32 South Africa breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 33 Saudi Arabia breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 34 UAE breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
Table 35 Kuwait breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Breast lesion localization methods market segmentation.
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data analysis models
Fig. 5 Market formulation and validation
Fig. 6 Data validating & publishing.
Fig. 7 Market snapshot
Fig. 8 Segment snapshot.
Fig. 9 Competitive landscape snapshot
Fig. 10 Breast lesion localization methods - market size and growth prospects (USD Million)
Fig. 11 Breast lesion localization methods market: Industry Value Chain Analysis
Fig. 12 Breast lesion localization methods market: Market Dynamics
Fig. 13 Breast lesion localization methods market: PORTER’s Five Forces Analysis
Fig. 14 Breast lesion localization methods market: PESTEL Analysis
Fig. 15 Breast lesion localization methods market share by type, 2023 & 2030 (USD Million)
Fig. 16 Breast lesion localization methods market, by type: market share, 2023 & 2030.
Fig. 17 Wire guided localization market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 18 Radioisotope localization market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 19 Radio guided occult-lesion localization (ROLL) market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 20 Radioactive-seed localization (RSL) market estimates & forecasts, 2018 - 2030 (Revenue, USD Million, Volume Unit)
Fig. 21 Others market estimates & forecasts, 2018 - 2030 (Revenue, USD Million, Volume Unit)
Fig. 22 Magnetic tracer market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 23 Others market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 24 Regional marketplace: key takeaways
Fig. 25 North America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 U.S. breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Canada breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Mexico breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Europe breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 UK breast lesion localization methods market estimates and forecasts, 2018 - 2030,) (USD Million)
Fig. 31 Germany breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 France breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Italy breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Spain breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Sweden breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Denmark breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Norway breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific Breast Lesion Localization Methods Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 39 China breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Japan breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 India breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 South Korea breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Australia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Thailand breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Latin America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Brazil breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Argentina breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 MEA breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Saudi Arabia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UAE breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Kuwait breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key company categorization
Fig. 54 Company market positioning
Fig. 55 Key company market share analysis, 2023
Fig. 56 Strategic framework